Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2016; 05(03): 137-138
DOI: 10.4103/2278-330X.187586
Editorial Commentary

Sarcomas: Difficult to tame tumors!

Jyoti Bajpai
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Shreyas Patel
MD Anderson Cancer Center, Texas
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
28 December 2020

© 2016. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dinshaw KA, Ganesh B. Hospital Based Cancer Registry. Annual Report 2001. Tata Memorial Hospital, Mumbai; 2005. p. 90-1.
  • 2 Jyoti B, Chandrashekharan A, Pandey N. Non-High Dose - Methotrexate (HD-MTX) Based, Dose-Dense (DD) Chemotherapy (CT) in Osteosarcoma: Is it Effective, Economic and Easy? - Presented at International Society of Pediatric Oncology Congress, Capetown; October, 2015.
  • 3 Rekhi B, Basak R, Desai SB, Jambhekar NA. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Indian J Med Res 2012;136:766-75.